Dr. Shirin Towfigh claims the medical device giant “knowingly copied” her design for a hernia device treatment.

Medtronic Plc is a ... Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and ...

Secondly, Medtronic's growth areas, including diabetes, electrophysiology, and surgical robotics, are seen as well-positioned ...

Medtronic announced today that it appointed Dr. Matthew Kroh as chief medical officer for Advanced and General Surgical Technologies.

A new medical technology fund which focusses on early-stage health technologies is itself an innovation. Utilizing its ...

Medtronic plc MDT is scheduled to report second-quarter fiscal 2025 results on Nov. 19, before the opening bell. In the last reported quarter, the company’s adjusted earnings of $1.23 exceeded the ...

I recommend selling Medtronic stock until it achieves significant innovation or operational ... known for its cardiac pacemakers, ablation products, and much more. So this is not a stock that ...

Secondary outcomes through 6 months were reported from the VenaSeal Spectrum Surgical Stripping study, a randomized ...

This growth is primarily driven by the rising prevalence of cardiovascular diseases (CVDs) worldwide, alongside continuous ...

(You can read the full research report on JPMorgan Chase here >>>) Medtronic’s shares have gained +8.3% over the year-to-date period against the Zacks Medical - Products industry’s gain of +12.0%.